Gremlin is overexpressed in lung adenocarcinoma and increases cell growth and proliferation in normal lung cells.
| Autor: | Mulvihill MS; Thoracic Oncology Laboratory, Department of Surgery, University of California San Francisco, San Francisco, California, United States of America., Kwon YW, Lee S, Fang LT, Choi H, Ray R, Kang HC, Mao JH, Jablons D, Kim IJ |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | PloS one [PLoS One] 2012; Vol. 7 (8), pp. e42264. Date of Electronic Publication: 2012 Aug 01. |
| DOI: | 10.1371/journal.pone.0042264 |
| Abstrakt: | Background: Gremlin, a member of the Dan family of BMP antagonists, is a glycosylated extracellular protein. Previously Gremlin has been shown to play a role in dorsal-ventral patterning, in tissue remodeling, and recently in angiogenesis. Evidence has previously been presented showing both over- and under-expression of Gremlin in different tumor tissues. Here, we sought to quantify expression of Gremlin in cancers of the lung and performed in vitro experiments to check whether Gremlin promotes cell growth and proliferation. Methodology/principal Findings: Expression of Gremlin in 161 matched tumor and normal lung cancer specimens is quantified by quantitative real-time PCR and protein level is measured by immunohistochemistry. GREM1 was transfected into lung fibroblast and epithelial cell lines to assess the impact of overexpression of Gremlin in vitro. Results: Lung adenocarcinoma but not squamous cell carcinoma shows a significant increase in Gremlin expression by mRNA and protein level. Lung fibroblast and epithelial cell lines transfected with GREM1 show significantly increased cell proliferation. Conclusions/significance: Our data suggest that Gremlin acts in an oncogenic manner in lung adenocarcinoma and could hold promise as a new diagnostic marker or potential therapeutic target in lung AD or general thoracic malignancies. |
| Databáze: | MEDLINE |
| Externí odkaz: |
|